000 01483 a2200445 4500
005 20250518042309.0
264 0 _c20191216
008 201912s 0 0 eng d
022 _a1757-790X
024 7 _a10.1136/bcr-2018-227475
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, Mee-Young
245 0 0 _aNovel
_h[electronic resource]
260 _bBMJ case reports
_cMay 2019
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdaptor Proteins, Signal Transducing
_xgenetics
650 0 4 _aAdult
650 0 4 _aAnastrozole
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAromatase Inhibitors
_xtherapeutic use
650 0 4 _aDiagnosis, Differential
650 0 4 _aEstrogen Antagonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHMGA2 Protein
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeuprolide
_xtherapeutic use
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMyxoma
_xdrug therapy
650 0 4 _aRare Diseases
650 0 4 _aTranscription Factors
_xgenetics
650 0 4 _aTranslocation, Genetic
_xgenetics
650 0 4 _aTreatment Outcome
650 0 4 _aVulvar Neoplasms
_xdrug therapy
650 0 4 _aYAP-Signaling Proteins
700 1 _ada Silva, Brandon
700 1 _aRamirez, Daniel C
700 1 _aMaki, Robert G
773 0 _tBMJ case reports
_gvol. 12
_gno. 5
856 4 0 _uhttps://doi.org/10.1136/bcr-2018-227475
_zAvailable from publisher's website
999 _c29743021
_d29743021